Translational Research on Adducts in Cancer Risk Identification and Prevention (U01)

This grant encourages clinically-relevant translational/epidemiological research projects focused on the use of adducts to cellular macromolecules, as indicators of exposures to cancer risk factors in human populations and subgroups. Projects are expected to be based on comprehensive use of human biospecimens for which detailed medical data are available (e.g., biospecimens from the NCI-supported cohort studies).

Funding: No fixed limit 

Duration: 5 years 

LOI (encouraged) due dates; 23.10.15, 11.6.16, 22.10.16, 11.6.17, 21.10.17, 11.6.18

Full application due dates: 23.11.15, 11.7.16, 22.11.16, 11.7.17, 21.11.17, 11.7.18